Tredje AP fonden grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 8.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,134 shares of the medical research company’s stock after acquiring an additional 3,500 shares during the period. Tredje AP fonden’s holdings in Agilent Technologies were worth $2,898,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in the company. Commerzbank Aktiengesellschaft FI lifted its position in shares of Agilent Technologies by 26.4% in the third quarter. Commerzbank Aktiengesellschaft FI now owns 13,232 shares of the medical research company’s stock worth $849,000 after buying an additional 2,765 shares in the last quarter. Skandinaviska Enskilda Banken AB publ lifted its position in shares of Agilent Technologies by 1.8% in the third quarter. Skandinaviska Enskilda Banken AB publ now owns 62,053 shares of the medical research company’s stock worth $3,984,000 after buying an additional 1,100 shares in the last quarter. KBC Group NV lifted its position in shares of Agilent Technologies by 67.7% in the third quarter. KBC Group NV now owns 810,906 shares of the medical research company’s stock worth $52,060,000 after buying an additional 327,316 shares in the last quarter. MUFG Americas Holdings Corp lifted its position in shares of Agilent Technologies by 185.9% in the third quarter. MUFG Americas Holdings Corp now owns 21,920 shares of the medical research company’s stock worth $1,407,000 after buying an additional 14,254 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its position in shares of Agilent Technologies by 1.4% in the third quarter. Schwab Charles Investment Management Inc. now owns 1,332,267 shares of the medical research company’s stock worth $85,532,000 after buying an additional 18,189 shares in the last quarter.

Several brokerages have weighed in on A. Robert W. Baird reissued a “buy” rating and set a $70.00 price objective on shares of Agilent Technologies in a research note on Friday, October 20th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research note on Tuesday, October 10th. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a research note on Tuesday, November 14th. Deutsche Bank set a $75.00 price objective on Agilent Technologies and gave the stock a “buy” rating in a research note on Tuesday, November 21st. Finally, Barclays boosted their price objective on Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 21st. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Agilent Technologies presently has a consensus rating of “Buy” and an average target price of $68.34.

In other news, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $69.56, for a total transaction of $347,800.00. Following the transaction, the insider now owns 75,504 shares of the company’s stock, valued at $5,252,058.24. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Jacob Thaysen sold 22,583 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $70.41, for a total value of $1,590,069.03. Following the transaction, the senior vice president now directly owns 63,042 shares in the company, valued at approximately $4,438,787.22. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 151,114 shares of company stock worth $10,359,388.

Shares of Agilent Technologies, Inc. (NYSE:A) opened at $66.24 on Tuesday. The firm has a market capitalization of $22,106.37, a P/E ratio of 28.98, a price-to-earnings-growth ratio of 2.08 and a beta of 1.27. Agilent Technologies, Inc. has a 52 week low of $44.11 and a 52 week high of $70.93. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.05. The firm had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.59 earnings per share. equities analysts predict that Agilent Technologies, Inc. will post 2.58 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Friday, December 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.90%. Agilent Technologies’s dividend payout ratio is currently 25.24%.

TRADEMARK VIOLATION NOTICE: “Agilent Technologies, Inc. (A) Shares Bought by Tredje AP fonden” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/agilent-technologies-inc-a-shares-bought-by-tredje-ap-fonden/1744955.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.